Goelzer Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Goelzer Investment Management, Inc.

$1.82 Billion
Q3 2025

A detailed history of Goelzer Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Goelzer Investment Management, Inc. holds 1,866 shares of VRTX stock, worth $809,881. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,866

Previous 1,899 1.74%

Holding current value

$809,881

Previous $845,000 13.61%

% of portfolio

0.04%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$366.54 - $479.53 $12,095 - $15,824	-33 Reduced 1.74%	1,866 $730,000
Q2 2025 Jul 09, 2025	BUY	$421.16 - $509.5 $2,526 - $3,057	6 Added 0.32%	1,899 $845,000
Q1 2025 Apr 28, 2025	BUY	$402.49 - $513.76 $7,244 - $9,247	18 Added 0.96%	1,893 $917,000
Q1 2025 Apr 22, 2025	SELL	$402.49 - $513.76 $16,099 - $20,550	-40 Reduced 2.09%	1,875 $909,000
Q4 2024 Jan 21, 2025	BUY	$396.64 - $516.74 $11,502 - $14,985	29 Added 1.54%	1,915 $771,000
Q3 2024 Oct 04, 2024	BUY	$460.0 - $505.78 $6,440 - $7,080	14 Added 0.75%	1,886 $877,000
Q2 2024 Aug 09, 2024	SELL	$392.81 - $485.53 $4,713 - $5,826	-12 Reduced 0.64%	1,872 $877,000
Q1 2024 May 01, 2024	SELL	$407.69 - $446.08 $6,930 - $7,583	-17 Reduced 0.89%	1,884 $787,000
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $73,402 - $87,885	-214 Reduced 10.12%	1,901 $773,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $57,152 - $61,255	169 Added 8.68%	2,115 $735,000
Q2 2023 Jul 26, 2023	SELL	$314.42 - $351.91 $41,503 - $46,452	-132 Reduced 6.35%	1,946 $684,000
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $29,172 - $33,279	-103 Reduced 4.72%	2,078 $654,000
Q4 2022 Jan 20, 2023	BUY	$285.76 - $321.48 $11,430 - $12,859	40 Added 1.87%	2,181 $0
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $40,253 - $44,912	147 Added 7.37%	2,141 $620,000
Q2 2022 Aug 01, 2022	BUY	$234.96 - $292.55 $44,172 - $54,999	188 Added 10.41%	1,994 $562,000
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $21,699 - $25,575	98 Added 5.74%	1,806 $471,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $1.7 Million - $2.15 Million	-9,609 Reduced 84.91%	1,708 $375,000
Q3 2021 Oct 29, 2021	BUY	$181.39 - $202.99 $1,088 - $1,217	6 Added 0.05%	11,317 $2.05 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $10,874 - $12,823	58 Added 0.52%	11,311 $2.28 Million
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $390,646 - $455,351	1,887 Added 20.15%	11,253 $2.42 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $203,283 - $271,120	982 Added 11.71%	9,366 $2.21 Million
Q3 2020 Oct 27, 2020	BUY	$255.65 - $303.1 $5,624 - $6,668	22 Added 0.26%	8,384 $2.28 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $72,379 - $94,951	321 Added 3.99%	8,362 $2.43 Million
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $606,701 - $752,598	3,037 Added 60.69%	8,041 $1.91 Million
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $834,216 - $1.12 Million	5,004 New	5,004 $1.1 Million

Others Institutions Holding VRTX

# of Institutions

1,791

Shares Held

231M

Call Options Held

1.84M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Goelzer Investment Management, Inc. with notifications on news.

Account

Goelzer Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History